Pharmacokinetics and Safety of Single Oral Doses of Emtricitabine in Human Immunodeficiency Virus-Infected Children

Emtricitabine (FTC; Emtriva), a potent deoxycytidine nucleoside reverse transcriptase inhibitor, has recently been approved by the U.S. Food and Drug Administration for the treatment of human immunodeficiency virus (HIV) infection. In adults, FTC has demonstrated linear kinetics over a wide dose ran...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wang, Laurene H., Wiznia, Andrew A., Rathore, Mobeen H., Chittick, Gregory E., Bakshi, Saroj S., Emmanuel, Patricia J., Flynn, Patricia M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2004
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC310155/
https://ncbi.nlm.nih.gov/pubmed/14693538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.1.183-191.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados